Related Experiment Video

Updated: Apr 26, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

9.4K

An orthosteric inhibitor of the RAS-SOS interaction

Seth Nickerson1, Stephen T Joy2, Paramjit S Arora2

  • 1Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, USA.

The Enzymes
|July 19, 2014
PubMed

Insights

Targeting the interaction between Rat sarcoma (RAS) proteins and Son of Sevenless (SOS) offers a novel therapeutic strategy. A helically constrained peptide mimic effectively inhibits RAS-SOS interaction, blocking RAS activation and downstream signaling.

Area of Science:

  • Molecular biology
  • Cell signaling
  • Drug discovery

Background:

  • Rat sarcoma (RAS) proteins are crucial signaling nodes regulating cell proliferation, migration, differentiation, and survival.
  • Dysregulation of RAS pathway components is implicated in numerous human diseases, but targeted therapies have faced challenges due to complex regulation.
  • The interaction between RAS and Son of Sevenless (SOS) is a rate-limiting step in RAS activation, involving a conserved catalytic helix from SOS.

Purpose of the Study:

  • To review RAS-SOS signaling dynamics and explore the therapeutic potential of inhibiting their interaction.
  • To present a novel method for generating helically constrained peptide mimics of protein surfaces.
  • To demonstrate the efficacy of an SOS-derived peptide mimic in inhibiting the RAS-SOS interaction.

Main Methods:

  • Review of existing literature on RAS-SOS signaling dynamics.
  • Development of a method for creating helically constrained peptide mimics.
  • Biochemical and functional assays to evaluate the inhibitory effect of the SOS mimic on RAS-SOS interaction and downstream signaling.

Main Results:

  • Evidence supports the inhibition of the RAS-SOS interaction as a viable therapeutic strategy.
  • A helically constrained peptide mimic was successfully designed based on SOS structure-function data.
  • The developed SOS mimic demonstrated biochemical and functional inhibition of the RAS-SOS active site interaction, blocking RAS activation.

Conclusions:

  • Inhibiting the RAS-SOS interaction represents a promising therapeutic paradigm for diseases involving RAS pathway dysregulation.
  • Helically constrained peptide mimics offer a novel approach to target protein-protein interactions, such as the RAS-SOS interface.
  • Blocking RAS-nucleotide exchange via SOS mimicry effectively inhibits RAS activation and downstream signaling pathways.
Keywords:
Helical peptide inhibitorHydrogen bond surrogateRASRASGEFSOS

More Related Videos

Comparing the Affinity of GTPase-binding Proteins using Competition Assays10:37

Comparing the Affinity of GTPase-binding Proteins using Competition Assays

Published on: October 8, 2015

12.1K
Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

10.3K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
5.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K
GTPases and their Regulation02:14

GTPases and their Regulation

2.4K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
7.9K